AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals
Faisal S. Ali(Beth Israel Deaconess Medical Center), Yngve Falck–Ytter(VA Northeast Ohio Healthcare System), Rubén Hernáez(Michael E. DeBakey VA Medical Center), Tracey G. Simon(Harvard University), Alejandro Piscoya(Universidad Tecnológica del Perú), Daniel Q. Huang(National University of Singapore), Mindie H. Nguyen(Stanford Medicine), Julius Wilder(Clinical Research Institute)
Cited by 72
Related Papers
Prevention of VTE in Orthopedic Surgery Patients
|CHEST Journal|2012|1.9k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
The global burden of metabolic disease: Data from 2000 to 2019
|Cell Metabolism|2023|777
AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis
|Gastroenterology|2020|327
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
|The Journal of Clinical Endocrinology & Metabolism|2022|306